Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-κB

Oncogene

Volumn 19, Issue 18, 2000, Pages 2233-2239

  Kajino, Shinichi ^a   Suganuma, Masashi ^a   Teranishi, Futoshi ^a   Takahashi, Naoko ^a   Tetsuka, Toshifumi ^a   Ohara, Hirotaka ^a   Itoh, Makoto ^a   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Carcinogenesis; Cycloheximide; NF B; TNF

Indexed keywords

ETICYCLIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

AGOUTI PACA;

EID: 0034720320     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203560     Document Type: Article

References (33)

1. Baeuerle PA. (1998). Cell, 95, 729-731.
2. Beg AA, Sha WC, Bronson RT, Ghosh S and Baltimore D. (1995). Nature, 376, 167-170.
3. Beg AA and Baltimore D. (1996). Science, 274, 782-784.
4. Baldwin Jr AS. (1996). Ann. Rev. Immun., 14, 649-683.
5. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY and Ballard DW. (1995). Mol. Cell. Biol., 15, 2809-2818.
6. Chu Z-L, McKinsey TA, Liu L, Gentry JJ, Malim MH and Ballard DW. (1997). Proc. Natl. Acad. Sci., 94, 10057-10062.
7. Fujiki H and Sugiura T. (1987). Adv. Cancer Res., 49, 223-264.
8. Gilmore TD, Koedood M, Piffat KA and White DW. (1996). Oncogene, 13, 1367-1378.
9. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sakaki K and Fujiki H. (1993). Cancer Res., 53, 1982-1985.
10. Kopp E and Ghosh S. (1994). Science, 265, 956-959.
11. Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dorken B and Scheidereit C. (1999). Oncogene, 18, 943-953.
12. Liu Z-G, Hsu H, Goeddel DV and Karin M. (1996). Cell, 87, 565-576.
13. Marx J. (1995). Science, 270, 232-233.
14. Mori T, Okamoto H, Takahashi N, Ueda R and Okamoto T. (2000). FEBS Lett., 465, 124-128.
15. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J and Ogihara T. (1997). Nat. Med., 3, 894-899.
16. Nicoletti I. Migliorati G, Pagliacci MC, Grignani F and Riccardi C. (1991). J. Immunol. Methods, 139, 271-279.
17. Okamoto T, Sakurada S, Yang J-P and Merin JP. (1997). Curr. Top. Cell. Regul., 35, 149-161.
18. Read JC. (1997). Nature. 387, 773-776.
19. Sakurada S, Kato T and Okamoto T. (1996). Int. Immunol., 8, 1483-1493.
20. Saliou C, Kitazawa M, McLaughlin L, Yang J-P, Lodge JK, Tetuska T, Iwasaki K, Cillard J, Okamoto T and Packer L. (1999). Free Radic. Biol. Med., 26, 174-183.
21. Sato T, Asamitsu K, Yang J-P, Takahashi N, Tetsuka T, Yoneyama A, Kanagawa A and Okamoto T. (1998). AIDS Res. Hum. Retrovir., 14, 293-298.
22. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatus K. Yamada K and Sugimura T. (1988). Proc. Natl. Acad. Sci. USA, 85, 1768-1771.
23. Suganuma M, Okabe S, Sucoka E, Iida N, Komori A, Kim S-J and Fujiki H. (1996). Cancer Res., 56, 3711-3715.
24. Thompson CB. (1995). Science, 267, 1456-1462.
25. Traber KE, Okamoto H, Kurono C, Baba M, Saliou C, Soji T, Packer L and Okamoto T. (1999). Int. Immunol., 11, 143-150.
26. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM. (1996). Science, 274, 787-789.
27. Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M and Fusco A. (1997). Oncogene, 15, 1987-1994.
28. Wang C-Y, Mayo MW and Baldwin Jr AS. (1996). Science, 274, 784-787.
29. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS. (1998). Science, 281, 1680-1683.
30. Wang C-Y, Cusack Jr JC, Liu R and Baldwin Jr AS. (1999). Nat. Med., 5, 412-417.
31. Wu MX, Ao Z, Prasad KVS, Wu R and Schlossman SS. (1998). Science, 281, 998-1001.
32. Yang J-P, Hori M, Takahashi N, Kawabe T, Kato H and Okamoto T. (1999). Oncogene, 18, 5177-5186.
33. Yoshida S, Kato T, Sakurada S, Kurono C, Yang J-P, Matsui N, Soji T and Okamoto T. (1999). Int. Immunol., 11, 151-158.